Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.45 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17548009 | 0.97 | SLC6A2 (0.47) | SLC6A2SLC6A4SLC6A3DAOMAOB | |
| SCHEMBL17548020 | 0.93 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3DAOMAOB | |
| SCHEMBL18503377 | 0.89 | HRH3 (0.40) | SLC6A2SLC6A4SLC6A3MAOBLMNA | |
| SCHEMBL27049743 | 0.87 | MAOB (0.37) | SLC6A2SLC6A4SLC6A3MAOBGPR84 | |
| SCHEMBL9979951 | 0.84 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3DAOMAOB | |
| SCHEMBL8153283 | 0.84 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3DAOMAOB | |
| SCHEMBL20259458 | 0.82 | SLC6A2 (0.46) | SLC6A2SLC6A4SLC6A3DAOMAOB | |
| SCHEMBL19011929 | 0.82 | MAOB (0.36) | SLC6A2SLC6A4SLC6A3MAOBGPR84 | |
| SCHEMBL17548039 | 0.82 | ESR2 (0.44) | SLC6A2SLC6A4SLC6A3DAOPTGS1 | |
| SCHEMBL19887761 | 0.81 | LMNA (0.38) | SLC6A2SLC6A4SLC6A3DAOLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3551723-B1 | ADDITIVES FOR LIQUID CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 2023-09-20 | — | — | EP | disclosed |
| WO-2022068499-A1 | THIOPHENE-CONTAINING LIQUID CRYSTAL COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | 北京八亿时空液晶科技股份有限公司 | 2022-04-07 | — | — | WO | disclosed |
| US-11053441-B2 | Liquid crystal composition and liquid crystal display device | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-07-06 | — | — | US | disclosed |
| US-10759997-B2 | Polymerizable compound, liquid crystal medium containing same and liquid crystal display device | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2020-09-01 | — | — | US | disclosed |
| US-20200123443-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-04-23 | — | — | US | disclosed |
| WO-2019233978-A1 | ADDITIVES FOR LIQUID-CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 2019-12-12 | — | — | WO | disclosed |
| EP-3037501-B1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DAINIPPON INK & CHEMICALS (JP) | 2019-03-27 | — | — | EP | disclosed |
| US-10174254-B2 | Nematic liquid crystal composition and liquid crystal display element using the same | DIC CORPORATION (JP) | 2019-01-08 | — | — | US | disclosed |
| US-20180163134-A1 | LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2018-06-14 | — | — | US | disclosed |
| WO-2018104285-A2 | ADDITIVES FOR LIQUID CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 2018-06-14 | — | — | WO | disclosed |
| EP-2735600-B1 | NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DAINIPPON INK & CHEMICALS (JP) | 2018-01-17 | — | — | EP | disclosed |
| US-20170260451-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING THE SAME | DIC CORPORATION (JP) | 2017-09-14 | — | — | US | disclosed |
| US-9624434-B2 | Nematic liquid crystal composition and liquid crystal display device using the same | DIC CORPORATION (JP) | 2017-04-18 | — | — | US | disclosed |
| US-20170029698-A1 | ANTIOXIDANT FOR LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE USING LIQUID CRYSTAL COMPOSITION | DIC CORPORATION (JP) | 2017-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10759997-B2 | Polymerizable compound, liquid crystal medium containing same and liquid crystal display device | BPHL, KLK3, NEFM | SLC6A2 3142/4885SLC6A4 2425/4885SLC6A3 2599/4885 |
| US-20170029698-A1 | ANTIOXIDANT FOR LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE USING LIQUID CRYSTAL COMPOSITION | GPX1, LPO, SCO2 | SLC6A2 2770/4885SLC6A4 4137/4885SLC6A3 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.